Friday, September 11, 2026

AI Terminator Fears Grow & Rates Breach 4.9% | The Weekly Wrap

Ten-year Treasury yields breach 4.9% as Steve Eisman discusses AI fears, OpenAI's price cut, Oracle's 30% revenue growth and Tesla's robotaxi setback.

TSLA $1.4TNVDA $5.5T

Steve Eisman Sep 11 2 clicks

Sep 11 LULU $11B

Lululemon: The 15-Minute Thesis

Hated Moats 2 clicks

Sep 11 LULU $11B

Why “Affordable Luxury” Doesn't Compound

MBI Deep Dives 2 clicks

From X

@TidefallCapital Sep 11

Trevor Scott on X

I'll never understand going long $ADBE at 14x '27 when you can buy $CSU.TO at 15x '27. Maybe because it's Canadian listed.

@negligible_cap Sep 11

Negligible Capital on X

*NVIDIA IN TALKS TO INVEST UP TO $10B IN ANTHROPIC IPO: REUTERS Anthropic is in talks with $NVDA to bring them on as an anchor investor in the IPO. Probably the least surprising news ever Anthropic is in talks to raise as much as $100B, which would beat out SpaceX Safety or not here they come

@negligible_cap Sep 11

Negligible Capital on X

*CORNING ENTERS UP TO $2B EQUITY DISTRIBUTION DEAL $GLW announces a $2B at-the-market offering of common stock. More supply inbound

@negligible_cap Sep 11

Negligible Capital on X

I simply refuse to believe that $ADBE has over 1 billion monthly active users https://t.co/U7tgBRDhM2

@KEDM_COM Sep 11 2 clicks

KEDM.com on X

Deckers Outdoor $DECK increased its buyback authorization by $3.5bn to $5bn. Not bad for a ~$11bn market cap. And it makes sense: msd-hsd topline growth, >20% EBITDA margins, over 70% FCF conversion, strong and rapidly increasing net cash position. They bought back ~6.5% of s/o last year. 10x EV/EBITDA seems too low.

@TidefallCapital Sep 11

Trevor Scott on X

The VMS thesis: "AI is actually a tailwind" "I think most people -this is not a fact in dispute that AI is TAM expanding for software. The debate is who's going to be the claim that TAM expansion. We have a strong thesis that incumbents have a high, high, high right to win." $ROP

@TidefallCapital Sep 11 1 click

Trevor Scott on X

"I've never been more excited than I have in my career about the opportunity in front of us with AI. We are literally delivering a button when you press it magic happens. And I've always been in like the boring part of software and all of a sudden, software is not boring." $ROP https://t.co/AIQZYxhy8R

@TidefallCapital Sep 11

Trevor Scott on X

"Product velocity through agentic use cases has increased. We're going through a massive amount of commercial learnings right now. Agentic AI products are hitting the market... The surface area software has just expanded massively because of AI." - $ROP (Citi 2026 TMT)

The Five Deals That Made Apollo

Apollo Global Management’s five defining deals, from Executive Life to Intel, built a $1 trillion asset manager spanning insurance and…

APO $74B

Net Interest Sep 11 1 click

In Conversation: NVIDIA

NVIDIA sees inference, agentic workloads and robotics broadening AI compute demand beyond hyperscalers, while high-speed memory shortages…

NVDA $5.5T

Aurelion Research Sep 11 1 click

Apple: Why iPhone Duo Will Likely Dominate The Foldables Market

Apple’s iPhone Duo foldable pairs a TSMC 2 nm chip, IP68 protection and iOS 27 features, positioning it against Samsung’s Galaxy Z Fold 8.

AAPL $5T

Mark Hibben Sep 11 1 click

Broadcom (NASDAQ: AVGO) Stock Rating: Upgrade To Accumulate From Do Nothing - Accumulation Zone And Stop Inside

Broadcom was upgraded to Accumulate at about $363 after Q3 revenue reached $29.6 billion, with AI semiconductor revenue up 221% to $16.7…

AVGO $1.7T

Cestrian Capital Research. Sep 11

TSOH Weekly Roundup (09/11/2026)

TSOH weekly roundup covers Meta’s child-safety settlement, Markel’s leadership transition, Peloton’s gym strategy and an upcoming Alarm.com…

META $1.7TMKL $22B

TSOH Investment Research Sep 11 2 clicks

Nucor Corporation: Steel Tariffs And Trade Spats

Nucor's growth and $250 fair value estimate hinge partly on the U.S.-Canada steel tariff dispute.

NUE $55B

Ray Merola Sep 11

Applied Materials (NASDAQ: AMAT) Stock Rating: Upgrade To Accumulate After Q3 FY10/26 Earnings - Accumulation Zone And Stop Inside

Applied Materials reported Q3 revenue of $9.1 billion, up 25%, and $2.3 billion in free cash flow as AMAT fell roughly 40% from its June…

AMAT $375B

Cestrian Capital Research. Sep 11

One of the Best Business Models in the World Just Went on Sale

AppLovin trades at 18 times EBITDA after a 57% drop, despite 84% EBITDA margins, rapid growth and a machine-learning advertising platform.

APP $104B

The Value Road Sep 10 5 clicks

The Williams Companies: A Tough Competitor Tackles The Northeast

Williams Companies faces a revoked Northeast pipeline permit while pursuing growth through Momentum Midstream, Gulf export access and…

WMB $87B

Long Player Sep 10

TransDigm is still in it for the money

TransDigm’s sole-source aerospace parts generate roughly 70% aftermarket margins, with 90% of revenue tied to owned IP and 80% from…

TDG $61B

scuttleblurb Sep 10 1 click

(C)riminally (V)alued (S)caled Healthcare Services

CVS Health fell 20% after cutting 2024 adjusted EPS guidance to $7, but its Aetna insurance and Caremark PBM businesses support a…

CVS $111B

Rod’s Ruminations May 1

Does anyone remember when Alnylam went up 50 percent in a day on a phase three result

Alnylam’s 2022 50% phase-three gain faces FDA advisory-panel scrutiny over its amyloidosis drug’s label extension.

ALNY $32B

John Hempton's Newsletter Sep 12

Value Roundup

Talen’s post-bankruptcy nuclear assets, FREIT’s $22 Kushner bid and Calithera’s failed liquidation vote illustrate unusual small-cap…

TLN $14B

Exploring with Alluvial Capital Jul 5

Going Nuclear with Nuveen

Nuveen municipal-bond closed-end funds could unlock illiquid Energy Harbor holdings through Vistra’s acquisition, receiving cash and a…

VST $47BFE $26B

Exploring with Alluvial Capital Mar 21

Essex Biotechnology (1061 HK) - Core products fund investment portfolio

Essex Biotechnology trades at 8 times earnings despite patented Chinese biologics, near-60% niche market share and a portfolio built with…

PFE $158B

Healthy Stock Picks Apr 5

Friday, September 11, 2026

AI Terminator Fears Grow & Rates Breach 4.9% | The Weekly Wrap

Lululemon: The 15-Minute Thesis

Why “Affordable Luxury” Doesn't Compound

From X

Trevor Scott on X

Negligible Capital on X

Negligible Capital on X

Negligible Capital on X

KEDM.com on X

Trevor Scott on X

Trevor Scott on X

Trevor Scott on X

Investor Letters

The Five Deals That Made Apollo

In Conversation: NVIDIA

Apple: Why iPhone Duo Will Likely Dominate The Foldables Market

Broadcom (NASDAQ: AVGO) Stock Rating: Upgrade To Accumulate From Do Nothing - Accumulation Zone And Stop Inside

TSOH Weekly Roundup (09/11/2026)

Nucor Corporation: Steel Tariffs And Trade Spats

Applied Materials (NASDAQ: AMAT) Stock Rating: Upgrade To Accumulate After Q3 FY10/26 Earnings - Accumulation Zone And Stop Inside

One of the Best Business Models in the World Just Went on Sale

The Williams Companies: A Tough Competitor Tackles The Northeast

TransDigm is still in it for the money

(C)riminally (V)alued (S)caled Healthcare Services

Does anyone remember when Alnylam went up 50 percent in a day on a phase three result

Value Roundup

Going Nuclear with Nuveen

Essex Biotechnology (1061 HK) - Core products fund investment portfolio

Publications we follow

YouTube 4

Blogs 12

Seeking Alpha 29 of 159

X accounts we follow

Investor letters we follow

Sectors

Friday, September 11, 2026

Trevor Scott on X

Negligible Capital on X

Negligible Capital on X

Negligible Capital on X

KEDM.com on X

Trevor Scott on X

Trevor Scott on X

Trevor Scott on X

Investor Letters

Publications we follow

Newsletters 91

YouTube 4

Blogs 12

Seeking Alpha 29 of 159

X accounts we follow

Investor letters we follow

Sectors